New Search

If you are not happy with the results below please do another search

1807 search results for:

1

Study presented at EHA21 looks at Pfizer/BioNTech SARS-COV-2 vaccine impairment in immunosuppressed patients

The European Hematology Association held their virtual congress from 9-17 June – it remains online until 15 August here. Many studies were presented, key among them was one titled: Humoral Response to the Pfizer/BioNTech BNT162b2 Vaccine Is Impaired in Patients Receiving CAR-T or High-Intensity Immunosuppressive Therapy. In the study the researchers evaluated the efficacy and […]

3

Researchers create bioengineered organism that could diagnose Crohn’s disease flareups

In an important step toward the clinical application of synthetic biology, Rice University researchers have engineered a bacterium with the necessary capabilities for diagnosing a human disease. The engineered strain of the gut bacteria E. coli senses pH and glows when it encounters acidosis, an acidic condition that often occurs during flareups of inflammatory bowel […]

8

New Cell Atlas of COVID lungs reveals why SARS-CoV-2 is different and deadly

  A new study published in Nature [1] draws the most detailed picture yet of SARS-CoV-2 infection in the lung, revealing mechanisms that result in lethal COVID-19, and may explain long-term complications and show how COVID-19 differs from other infectious diseases. Led by researchers at Columbia University Vagelos College of Physicians and Surgeons and Herbert Irving […]

9

RESPIRE trial of therapeutic for all strains of COVID-19 gets underway in Germany

  Investigators hope ATR-002 drug will also be effective against ‘Long-Covid’   Tübingen, Germany-based Atriva Therapeutics, a biopharmaceutical company that is pioneering the development of host-targeting antiviral therapies, has enrolled its first patient in its Phase II RESPIRE [1] trial in COVID-19. Prof. Martin Witzenrath, M.D., Vice Director Department of Infectious Diseases and Respiratory Medicine, […]